Company Information
Nobel Biocare Holding AG
Othmarstrasse 8
8008 Zürich
Switzerland
+41 41 340 30 40
http://www.nobelbiocare.com/
- CEO
- Heliane Canepa
- Investor Relations
- Gunilla Ekholtz
Nobel Biocare develops, produces, and markets dental implants and IT-based industrialised dental prosthetics. The company operates two business units: Dental implant, which makes permanent replacements for lost teeth, and Procera, which produces dental copings and dental bridges using a unique computer-aided design/computer-aided manufacture (CAD/CAM) based manufacturing process.
Trading Information
- Sector
- Health Care - 4500
- Regulatory Standard
- International Reporting Standard
- Security Number
- 1403004
- ISIN
- CH0014030040
- Symbol
- NOBE
- Index member
- SPI
Intermediaries
- Listing Agent
- UBS Warburg
- Lead Bank
- -
- Auditor
- KPMG Fides
Information on the Issue
| Security Details | |
|---|---|
| First Listing | 24.06.2002 |
| Class of Share | Bearer Share |
| Nominal Value | 2.00 CHF |
| Total Shares outstanding (post issue; incl. Greenshore - if any) | 24005242 |
| Allocation Details | |
|---|---|
| Primary Shares | 24005242 |
| Secondary Shares | n/a |
| Primary Greenshoe | n/a |
| Secondary Greenshoe | n/a |
| Greenshoe Details | |
|---|---|
| Executed | no GS at all |
| Ex-date | n/a |
| Executed number of shares | n/a |
| First Trading Day Details | |
|---|---|
| First Trading | 24.06.2002 |
| Price Range | n/a |
| Issue Price | n/a |
| First Open | 100.00 CHF |
| First Close | 106.00 CHF |
| Transaction size in Mio. (incl. executed Greenshoe) | 0 CHF |
| Market Capitalisation in Mio. (based on first closing price) | 2544.6 CHF |
Financial Statement
| Number of Employees | 1328 2001 |
| Net Revenues in Mio. | 2.7 SEK 2001 |
| Net Gain in Mio. | n/a |